•  
  •  
 

Article Type

Article

Abstract

More than 230 million people undergo surgery each year worldwide, and the number is increasing annually. Surgery commonly causes postoperative pain that should be alleviated as soon and as effectively as possible to reduce suffering, promote the healing process and rehabilitation, and prevent complications. However, clinical pain management after surgery remains far from successful despite the dramatically increased scientific evidence in this area. Many patients suffer from severe pain after surgery. Aim: The aim of this study is to compare between ketorolac and nefopam when administered intravenously as post-operative analgesia in cesarean section. Patients and methods: 60 patients, who were candidates for elective and emergency cesarean section, were randomly assigned to receive an intravenous infusion of Nefopam (Group A) or an intravenous infusion of Ketorolac (Group B) during anesthesia induction. All patients received a Tramadol ampule of 100 mg after the delivery of the baby as analgesia. The patients were also monitored for the development of sweating, nausea, and vomiting, along with vital signs during the recovery phase. Results: There was a significant difference between Group A (Nefopam) and Group B (Ketorolac) regarding the Numerical Rating Scale (NRS) and patient satisfaction. Conclusions: Nefopam is more effective than ketorolac in controlling pain for patients undergoing cesarean section.

Keywords

Ketorolac, Nefopam, Cesarean section, Pain.

Share

COinS